Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study
Topalian SL, Salmon D, Avis FP, et al. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 1988;6(5):839.
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
Rosenberg SA, Spiess P, Lafrenier R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986;233:1318.
Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in combinant interleukin-2
Takagi S, Chen K, Schwarz R, et al. Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in combinant interleukin-2. Cancer 1989;1:102.
Characterization of human autotumor reactive T cell clones obtained from tumorinfiltrating lymphocytes in liver metastasis of gastric carcinoma
Shimizu Y, Weidmann E, Iwatsuki S, et al. Characterization of human autotumor reactive T cell clones obtained from tumorinfiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 1991;11(15):6153.
Distribution and therapeutic effect of intraarterially tranferred tumor-infiltrating lymphocytes in hepatic malignancies
Takayama T, Makuuchi M, Sekine T, et al. Distribution and therapeutic effect of intraarterially tranferred tumor-infiltrating lymphocytes in hepatic malignancies. Cancer 1991;12 (1):2391.